About Bioline  All Journals  Testimonials  Membership  News  Donations

International Journal of Reproductive BioMedicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
ISSN: 1680-6433
EISSN: 2008-2177
Vol. 17, No. 5, 2019, pp. 371-374
Bioline Code: rm19039
Full paper language: English
Document type: Case Report
Document available free of charge

International Journal of Reproductive BioMedicine, Vol. 17, No. 5, 2019, pp. 371-374

 en Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
Talebi, Mehrdad; Mehrjardi, Mohammad Yahya Vahidi; Kalhor, Kambiz & Dehghani, Mohammadreza


Background: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease.
Case: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 𝜇g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 𝜇mol/L; reference range, 236–410 𝜇mol/L), glutamine (2,256 𝜇mol/L; reference range, 20–107 𝜇mol/L), asparagine (126 𝜇mol/L; reference range, 30–69 𝜇mol/L), glutamic acid (356 𝜇mol/L; reference range, 14–192 𝜇mol/L), aspartic acid (123 𝜇mol/L; reference range, 0–24 𝜇mol/L), and lysine (342 𝜇mol/L; reference range, 114–269 𝜇mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G > C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously.
Conclusion: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs.

CPS1 deficiency; Hyperammonemia; Urea cycle disorder; Whole exome sequencing.

© Copyright 2019 - Mehrdad Talebi et al.
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 29-Jan-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil